Recombinant Human p85/p110 Protein (Baculovirus)，Avi

The P85/P110 complex, composed of the regulatory subunit P85 and the catalytic subunit P110 of phosphoinositide 3-kinase (PI3K), plays a critical role in cellular signaling pathways that regulate various cellular functions, including growth, proliferation, and metabolism. Research into P85/P110 has gained prominence due to its involvement in cancer progression and other diseases, where aberrant PI3K signaling is often implicated. The PI3K pathway is activated by various growth factors and hormones, leading to the production of phosphatidylinositol-(3,4,5)-trisphosphate (PIP3), which serves as a secondary messenger to activate downstream signaling proteins such as AKT. Dysregulation of this pathway can lead to uncontrolled cell division and survival, highlighting its significance as a therapeutic target. Understanding the structural and functional dynamics of P85/P110 not only illuminates the mechanistic underpinnings of PI3K-related diseases but also paves the way for the development of specific inhibitors that could be used in clinical settings. Recent studies have focused on the detailed characterization of P85/P110 interactions, their regulatory mechanisms, and the impact of various mutations associated with cancer, providing insights that are crucial for designing targeted therapies aimed at modulating this pathway. As a result, the P85/P110 complex remains a vital subject of investigation within cancer biology and drug development, with the potential to contribute to more effective treatment strategies against malignancies driven by PI3K pathway alterations.